Correlation Between Biora Therapeutics and Elevation Oncology
Can any of the company-specific risk be diversified away by investing in both Biora Therapeutics and Elevation Oncology at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Biora Therapeutics and Elevation Oncology into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Biora Therapeutics and Elevation Oncology, you can compare the effects of market volatilities on Biora Therapeutics and Elevation Oncology and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Biora Therapeutics with a short position of Elevation Oncology. Check out your portfolio center. Please also check ongoing floating volatility patterns of Biora Therapeutics and Elevation Oncology.
Diversification Opportunities for Biora Therapeutics and Elevation Oncology
0.17 | Correlation Coefficient |
Average diversification
The 3 months correlation between Biora and Elevation is 0.17. Overlapping area represents the amount of risk that can be diversified away by holding Biora Therapeutics and Elevation Oncology in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Elevation Oncology and Biora Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Biora Therapeutics are associated (or correlated) with Elevation Oncology. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Elevation Oncology has no effect on the direction of Biora Therapeutics i.e., Biora Therapeutics and Elevation Oncology go up and down completely randomly.
Pair Corralation between Biora Therapeutics and Elevation Oncology
Given the investment horizon of 90 days Biora Therapeutics is expected to under-perform the Elevation Oncology. But the stock apears to be less risky and, when comparing its historical volatility, Biora Therapeutics is 1.41 times less risky than Elevation Oncology. The stock trades about -0.11 of its potential returns per unit of risk. The Elevation Oncology is currently generating about 0.01 of returns per unit of risk over similar time horizon. If you would invest 172.00 in Elevation Oncology on September 2, 2024 and sell it today you would lose (108.00) from holding Elevation Oncology or give up 62.79% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Biora Therapeutics vs. Elevation Oncology
Performance |
| Timeline |
| Biora Therapeutics |
| Elevation Oncology |
Biora Therapeutics and Elevation Oncology Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Biora Therapeutics and Elevation Oncology
The main advantage of trading using opposite Biora Therapeutics and Elevation Oncology positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Biora Therapeutics position performs unexpectedly, Elevation Oncology can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Elevation Oncology will offset losses from the drop in Elevation Oncology's long position.| Biora Therapeutics vs. Enveric Biosciences | Biora Therapeutics vs. Elevation Oncology | Biora Therapeutics vs. Hepion Pharmaceuticals | Biora Therapeutics vs. Zura Bio Limited |
| Elevation Oncology vs. Ocean Biomedical | Elevation Oncology vs. Zura Bio Limited | Elevation Oncology vs. Enveric Biosciences | Elevation Oncology vs. Hepion Pharmaceuticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Efficient Frontier module to plot and analyze your portfolio and positions against risk-return landscape of the market..
Other Complementary Tools
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume |